Genetic analysis of azole resistance by transposon mutagenesis in Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 11, 1999, Pages 2731-2735

  Kontoyiannis, D P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHOTERICIN B; CANAVANINE; CYCLOHEXIMIDE; FLUCONAZOLE; FLUOROURACIL; NYSTATIN; PYRROLE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; DRUG SCREENING; FUNGUS MUTATION; GENE FUSION; GENOTYPE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RECESSIVE GENE; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION REGULATION; TRANSPOSON;

EID: 0032726356     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.11.2731     Document Type: Article

References (20)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990 Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Balzi, E., M. Wang, S. Leterme, L. Dyck, and A. Goffeau. 1994. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J. Biol. Chem. 269:2206-2214.
3. Burns, N. B., P. B. Grimwade, E. Y. Ross-Macdonald, K. Choi, K. Finbery, G. S. Roeder, and M. Synder. 1994. Large-scale analysis of gene expression, protein localization, and gene disruption in Saccharomyces cerevisiae. Genes Dev. 8:1087-1105.
4. Decottignies, A., and A. Goffeau. 1997. Complete inventory of the yeast ABC proteins. Nat. Genet. 15:137-145.
5. DeRisi, J. L., V. R. Iyer, and P. O. Brown. 1997. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278:680-686.
6. Gansheroff, L. J., C. Dollard, P. Tan, and F. Winston. 1995. The Saccharomyces cerevisiae SPT7 gene encodes a very acidic protein important for transcription in vivo. Genetics 139:523-536.
7. Garrels, J. I. 1994. YPD - a database for the proteins of Saccharomyces cerevisiae. Nucleic Acids Res. 24:46-49.
8. Grant, P. A., D. E. Sterner, L. J. Duggan, J. L. Workman, and S. Berger. 1998. The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes. Trends Cell. Biol. 8:193-197.
9. Hampsey, M. 1998. Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiol. Mol. Biol. Rev. 62:465-503.
10. Hernaez, M. L., C. Gil, J. Pla, and C. Nombela. 1998. Induced expression of Candida albicans multidrug resistance gene in response to fluconazole and other antifungals. Yeast 14:517-526.
11. Joseph-Horne, T., and D. W. Hollomon. 1997. Molecular mechanisms of azole resistance in fungi. FEMS Microbiol. Lett. 149:141-149.
12. Kaiser, C., S. Michaelis, and A. Mitchell. 1994. Methods in yeast genetics. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
13. Kelly, S. L., A. Arnoldi, and D. Kelly. 1993. Molecular genetic analysis of azole antifungal mode of action. Biochem. Soc. Trans. 21:1034-1038.
14. Martens J. A., J. Genereaux, A. Saleh, and C. J. Brandl. 1996. Transcriptional activation by yeast PDR1p is inhibited by its association with NGG1p/ ADA3p. J Biol. Chem. 271:15884-15890.
15. Paultauf, F., S. D. Kohlwein, and S. A. Henry. 1992. Regulation and compartmentalization of lipid synthesis in yeast, p. 415-500. In E. W. Jones, J. R. Pringle, and J. R. Broach (ed.), The molecular and cellular biology of the yeast Saccharomyces. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
16. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Billie. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
17. Smith, S. J., J. H. Crowley, and L. W. Parks. 1996. Transcriptional regulation by ergosterol in the yeast Saccharomyces cerevisiae, Mol. Cell. Biol. 16:5427-5432.
18. Sutter, T. R., and J. C. Loper. 1989. Disruption of the Saccharomyces cerevisiae gene for NADPH-cytochrome P450 reductase causes increased sensitivity to ketoconazole. Biochem. Biophys. Res. Commun. 160:1257-1266.
19. Vanden Bossche, H., L. Koymans, and H. Moereels. 1995. P450 inhibitors of use in medical treatment: focus on mechanisms of action. Pharmacol. Ther. 67:79-100.
20. White, T., K. Marr, and R. Bowden. 1998. Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.